Medical News

RSS

Molecular Endocrinology journal publishes two studies on estrogen hormones

University of Houston (UH) researchers have their sights set on developing possible treatments for breast and colon cancer.

23 Aug 2011

USAID helps improve maternal, child health care at Pakistani hospital

This post in the State Department's "DipNote" blog looks at Fatima Jinnah Women's Hospital, "one of more than 80 Pakistani medical facilities that the United States has helped renovate in recent years in Pakistan" and describes how medical personnel at the facility "demonstrated the benefits that new equipment and training opportunities have made to their standard of care on Thursday, August 18, as U.S. Agency for International Development Mission Director Andrew Sisson toured the facility."

23 Aug 2011

CVS Caremark announces results of Consent Solicitation from registered holders

CVS Caremark Corporation announced today the results of its previously announced solicitation of consents from the registered holders as of 5:00 p.m., New York City time on August 8, 2011 of its 6.125% Senior Notes due August 15, 2016 to terminate the replacement capital covenant, which was entered into on May 25, 2007, for the benefit of the holders of the Notes in connection with the issuance of its 6.302% Enhanced Capital Advantaged Preferred Securities due 2062.

23 Aug 2011

CompTIA to offer live healthcare IT training sessions in Los Angeles, Chicago

Training programs designed to help information technology (IT) companies broaden their business skills and knowledge in the emerging areas of healthcare IT and unified communications are available in the coming weeks from CompTIA, the non-profit association for the IT industry.

23 Aug 2011

Aptiv Solutions acquires Medical Device Consultants

Aptiv Solutions announced today the acquisition of Medical Device Consultants, Inc. (MDCI), a provider of expert medical device consulting and clinical trial management and execution.

23 Aug 2011

OICR President announces $12.6M in funding for High Impact Clinical Trials Program

Dr. Tom Hudson, President and Scientific Director of the Ontario Institute for Cancer Research (OICR), today announced $12.6 million in funding over four years for OICR's High Impact Clinical Trials (HICT) Program.

23 Aug 2011

UNICEF warns Horn of Africa 'crisis will get worse'; China contributes $16M in aid funds to WFP

UNICEF Executive Director Anthony Lake told reporters on Friday that "more than 300,000 children in the Horn of Africa are severely malnourished 'and in imminent risk of dying' because of drought and famine," the Associated Press/Washington Post reports.

23 Aug 2011

Nepstar second quarter revenue increases 7.3% to US$93.8 million

China Nepstar Chain Drugstore Ltd., the largest retail drugstore chain in China based on the number of directly operated stores, today announced its unaudited financial results for the second quarter ended June 30, 2011.

23 Aug 2011

Symphogen initiates Sym004 Phase 2 trial in squamous cell carcinoma of head and neck cancer

Symphogen A/S today announced the initiation of a Phase 2 clinical trial to investigate the safety and efficacy of Sym004 in patients who have failed anti-EGFR monoclonal antibody (mAb)-based therapy, with recurrent and/or metastatic squamous cell carcinoma of the head and neck.

23 Aug 2011

Radium-223 chloride granted FDA Fast Track designation for treatment of CRPC

Algeta ASA, a company focused on the development of novel targeted cancer therapeutics, today announced that radium-223 chloride has been granted Fast Track designation by the U.S. Food and Drug Administration (FDA) for the treatment of castration-resistant (hormone refractory) prostate cancer in patients with bone metastases.

23 Aug 2011

Research into TB medication may shorten treatment regimen

Research of the common tuberculosis (TB) drug pyrazinamide, which is used in combination with other medications to treat the disease in a six-month regimen, "has now revealed that the drug does kill the latent form of the microbe, which does not cause observable symptoms," VOA News reports.

23 Aug 2011

Survival for patients with HCC increases with radioembolization

Analysis revealed survival for patients with hepatocellular carcinoma (HCC) is achievable using 90Y-resin microsphere radioembolization. The analysis conducted at multiple centers across Europe showed that the procedure is likely to provide survival benefit across different tumor stages, including patients with advanced liver cancer and with limited treatment options.

23 Aug 2011

Phadia launches new allergy and autoimmunity testing instruments

Today Phadia, the global leader in allergy and autoimmune related diseases diagnostics, announced the launch of Phadia's new allergy and autoimmunity testing instruments; Phadia 2500 and Phadia 5000.

23 Aug 2011

Prenatal smoking affects early neurological development in babies

In one of the largest studies of its kind to date, researchers have found that babies born to mothers who smoke while pregnant face substantial delays in early neurological development, and the effects may be stronger than researchers had previously thought.

23 Aug 2011

China Medicine Audit Committee dismisses auditor Frazer Frost

China Medicine Corporation, a leading manufacturer, developer and distributor of Western pharmaceuticals, traditional Chinese medicines, and other health products in the People's Republic of China, today announced that the Audit Committee of the Board of Directors of the Company, has dismissed Frazer Frost as the Company's independent auditor, effective August 16, 2011.

23 Aug 2011

Ventas receives court ruling to collect $102 million from judgment against HCP

Ventas, Inc. said today that the United States District Court for the Western District of Kentucky has ruled that Ventas may immediately collect the $102 million compensatory damages judgment against HCP, Inc. that it was awarded by a federal jury in 2009.

23 Aug 2011

Santarus, Depomed enter new commercialization agreement for GLUMETZA

Santarus, Inc. and Depomed, Inc. today announced that they have entered into a new commercialization agreement for GLUMETZA (metformin hydrochloride extended release tablets) under which Santarus will assume broad commercial, manufacturing and regulatory responsibilities to replace a promotion agreement that the companies entered into in July 2008.

23 Aug 2011

IsoRay Cs-131 mesh brachytherapy with da Vinci Robot for lung cancer treatment gains momentum

IsoRay, Inc. said today that a growing number of hospitals and medical treatment centers are adopting its proprietary mesh Cesium-131 (Cs-131) brachytherapy seeds (internal radiation therapy) for use in conjunction with the da Vinci® Surgical System to treat early stage lung cancer patients. One of the most recent adopters is Georgia's Archbold Memorial Hospital.

23 Aug 2011

MedClean second quarter total revenue increases 44.6% to $190,557

MedClean Technologies, Inc. today announced financial results for the second quarter ended June 30, 2011.

23 Aug 2011

Scientists identify molecular pathway that plays a key role in stress-related DNA damage

Working closely with a team of researchers from Duke University, scientists from the Florida campus of The Scripps Research Institute have helped identify a molecular pathway that plays a key role in stress-related damage to the genome, the entirety of an organism's hereditary information.

23 Aug 2011